Kadmon Holdings, Inc.

Please note: The information displayed on this page might be outdated.
Kadmon Holdings, Inc.: Aug 30 PDUFA data for belumosudil (cGVHD) following positive primary analysis results (May 2020); observed ORRs of 73% and 74% in 200mg QD and 200mg BID arms, respectively. Initiating 12-15 pt open-label Ph 2 in patients w diffuse cutaneous systemic sclerosis in Q1 2021. First 3-pt dose cohort successfully completed in ongoing dose-escalation Ph 1 (anti-PD-L1/IL-15 fusion protein) in patients w metastatic or locally advanced solid tumors; enrollment ongoing in next dose level. Continuing IND-enabling activities of KD045, Kadmon's next-gen ROCK inhibitor for treatment of fibrotic diseases.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Phase III
Disease Space
Autoimmune, Fibrosis, Immunotherapy, Oncology
Industry
Biotechnology, Pharmaceuticals
Listing
Public, USA
Market Cap
500MM - 1B
Website:
Profiles:
Address:
450 East 29th Street
New York, NY 10016
United States

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Harlan W. Waksal, MD, President & Chief Executive Officer

Lead Programs

KD025

Indication Phase
Chronic Graft-Versus-Host Disease 2
Systemic Sclerosis 2
Idiopathic Pulmonary Fibrosis 2

KD034

Indication Phase
Wilson’s Disease 3

Top 10 Holders of Kadmon Holdings Inc Warrant 2017-28.09.22 On Kadmon Hldngs

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Sofinnova Investments, Inc. 0.00 0 0.00 13F 3/31/21

Top 10 Holders of Kadmon Holdings, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Perceptive Advisors LLC 9.14 15,711,334 64.57 13F 3/31/21
State Street Corp. 7.53 12,930,224 53.14 13F 3/31/21
Point72 Asset Management LP (Old) 6.86 11,785,115 48.44 13F 3/31/21
SSgA Funds Management, Inc. 5.72 9,815,097 40.34 Stakes 12/31/20
Avidity Partners Management LP 5.55 9,544,200 39.23 13F 3/31/21
Point72 Asset Management LP 5.28 9,049,800 37.19 Stakes 1/13/21
The Vanguard Group, Inc. 5.25 9,002,368 37.00 Stakes 12/31/20
Vanguard Group, Inc. (Subfiler) 5.04 8,658,772 35.59 13F 3/31/21
BlackRock Fund Advisors 4.70 8,071,604 33.17 13F 3/31/21
Third Point LLC 4.42 7,601,115 31.24 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.